The Food and Drug Administration has approved Ofirmev for the treatment of pain and fever in adults and children, according to a Pain Medicine News report.
Ofirmev, a Cadence Pharmaceuticals product, is the first form of intravenous acetaminophen in the U.S. Cadence Pharmaceuticals is expected to launch the product in the early part of this year, according to the news report.
Read the news report about Ofirmev.
Read other coverage about FDA approvals:
- FDA Approves Mindray Medical Anesthesia System
- House Hears Arguments Over FDA's Medical Device Approval Process
- 7 GI/Endoscopy Devices Receive FDA Approval
Ofirmev, a Cadence Pharmaceuticals product, is the first form of intravenous acetaminophen in the U.S. Cadence Pharmaceuticals is expected to launch the product in the early part of this year, according to the news report.
Read the news report about Ofirmev.
Read other coverage about FDA approvals:
- FDA Approves Mindray Medical Anesthesia System
- House Hears Arguments Over FDA's Medical Device Approval Process
- 7 GI/Endoscopy Devices Receive FDA Approval